Study S002785

Pharmacokinetic Study of HR17031 Injection in Healthy Subjects (Single-center, Randomized, Open-label, 4 Cycles, 4 Sequences)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05031871
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2021-09-02
Primary completion: 2021-11-19
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:HR17031 injection ；INS068 injection；SHR20004 injection
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Cmax：Maximum observed concentration [Day1 to Day 26]
AUC0-t ：Area under the curve from the time of dosing time to the last measurable (positive) concentration； [Day1 to Day 26]
AUC0-inf：Area under the curve from time 0 to infinity； [Day1 to Day 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.